Trial intelligence / Profile preview

LSD-assisted psychotherapy for anxiety in life-threatening illness

NCT00920387Phase 2Completed

Sponsor
Multidisciplinary Association for Psychedelic Studies
Start
Feb 2008
Primary completion
Apr 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of Lysergide in anxiety disorder, sponsored by Multidisciplinary Association for Psychedelic Studies. Started Feb 2008; status: completed.

02

Drugs

Lysergide
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on NCT00920387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00920387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call